Form 4: ADMA Biologics Director Exercises Options and Sells Shares

Lawrence P. Guiheen, a director at ADMA Biologics, exercised stock options and sold shares of common stock on September 9, 2024.

Summary

• On September 9, 2024, Lawrence P. Guiheen, a director of ADMA Biologics, exercised options to purchase 9,000 shares of common stock at a price of $10.80 per share.
• Simultaneously, Guiheen sold 9,000 shares at a weighted average price of $18.4654, with individual sales ranging from $18.465 to $18.47.
• Following these transactions, Guiheen directly owns 153,941 shares and indirectly owns 1,000 shares through the Guiheen Trust.
• He also holds 12,020 restricted stock units that will vest on February 26, 2025, contingent upon continued service.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reflects routine insider trading activity (option exercise and sale) with no explicit indication of positive or negative outlook.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Option exercises and subsequent sales are common, especially as expiration dates approach.

Key Dates